These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6354932)

  • 1. Hemodynamic and humoral interactions between captopril and nifedipine.
    Stornello M; Di Rao G; Iachello M; Pisani R; Scapellato L; Pedrinelli R; Salvetti A
    Hypertension; 1983; 5(5 Pt 2):III154-6. PubMed ID: 6354932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihypertensive and hormonal effects of single oral doses of captopril and nifedipine in essential hypertension.
    Soto ME; Thibonnier M; Sire O; Menard J; Corvol P; Milliez P
    Eur J Clin Pharmacol; 1981; 20(3):157-61. PubMed ID: 7026255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium-channel blockade with nifedipine and angiotensin converting-enzyme inhibition with captopril in the therapy of patients with severe primary hypertension.
    Guazzi MD; De Cesare N; Galli C; Salvioni A; Tramontana C; Tamborini G; Bartorelli A
    Circulation; 1984 Aug; 70(2):279-84. PubMed ID: 6375889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma renin activity and norepinephrine as predictors for antihypertensive effects of nifedipine and captopril.
    Kusaka M; Atarashi K; Matsumoto K; Sumida Y; Matsuura H; Shingu T; Kajiyama G
    Am J Hypertens; 1991 Sep; 4(9):735-9. PubMed ID: 1930858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humoral and hemodynamic effects of increasing doses of captopril in patients with essential hypertension.
    Sassano P; Pedrinelli R; Magagna A; Abdel-Haq B; Salvetti A
    Am J Cardiol; 1982 Apr; 49(6):1574-6. PubMed ID: 6280486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose response in captopril therapy of hypertension.
    Lijnen P; Fagard R; Staessen J; Verschueren LJ; Amery A
    Clin Pharmacol Ther; 1980 Sep; 28(3):310-5. PubMed ID: 6250759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Captopril and nifedipine in combination for moderate to severe essential hypertension.
    Singer DR; Markandu ND; Shore AC; MacGregor GA
    Hypertension; 1987 Jun; 9(6):629-33. PubMed ID: 3294594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the effects of captopril, diuretic and their combination in low- and normal-renin essential hypertension.
    Ferguson RK; Vlasses PH; Swanson BN; Mojaverian P; Koplin JR
    Life Sci; 1982 Jan; 30(1):59-65. PubMed ID: 7033708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of inhibition of converting enzyme by captopril on arterial pressure, renin and aldosterone in essential hypertension].
    Posadas C; Sánchez G; Boyer JL; Delmar M; Serrano PA
    Arch Inst Cardiol Mex; 1982; 52(4):295-300. PubMed ID: 6291470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of converting enzyme inhibition on blood pressure, plasma renin activity (PRA) and plasma aldosterone in hypertensive diabetics compared to patients with essential hypertension.
    Sullivan PA; Kelleher M; Twomey M; Dineen M
    J Hypertens; 1985 Aug; 3(4):359-63. PubMed ID: 2995484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antihypertensive and humoral effects of nifedipine in essential hypertension uncontrolled by hydrochlorothiazide alone.
    Opsahl JA; Halstenson CE; Abraham PA
    Am J Hypertens; 1989 Nov; 2(11 Pt 1):828-33. PubMed ID: 2686710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Converting enzyme inhibition with captopril in patients with primary hyperaldosteronism.
    Luderer JR; Demers LM; Harrison TS; Hayes AH
    Clin Pharmacol Ther; 1982 Mar; 31(3):305-11. PubMed ID: 6277545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Captopril and nifedipine interactions in the treatment of essential hypertensives: a crossover study.
    Salvetti A; Innocenti PF; Iardella M; Pambianco F; Saba GC; Rossetti M; Botta GF
    J Hypertens Suppl; 1987 Dec; 5(4):S139-42. PubMed ID: 3326920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A discrepancy between the effects of a single oral dose of captopril on blood pressure, plasma renin activity, and serum angiotensin-converting enzyme levels.
    Lechi A; Covi G; Capuzzo MG; Lechi C; Minuz P; Delva P; Scuro LA
    Int J Clin Pharmacol Ther Toxicol; 1983 Nov; 21(11):569-74. PubMed ID: 6317579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of food on acute and chronic effects of captopril in essential hypertensive patients.
    Salvetti A; Pedrinelli R; Magagna A; Abdel-Haq B; Graziadei L; Taddei S; Stornello M
    J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S25-9. PubMed ID: 2580172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of captopril on arterial and venous pressure, renal function, and humoral factors in severe chronic congestive heart failure.
    Kubo S; Nishioka A; Nishimura H; Kawamura K; Takatsu T
    Clin Pharmacol Ther; 1984 Oct; 36(4):456-63. PubMed ID: 6206977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of captopril on blood pressure and on the renin-angiotensin-aldosterone system in coarctation of the aorta.
    Fallo F; Maragno I; Merola P; Mantero F
    Clin Exp Hypertens A; 1983; 5(3):321-8. PubMed ID: 6340859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of plasma and urinary vasopressin during treatment of severe hypertension by captopril.
    Thibonnier M; Soto ME; Menard J; Aldiger JC; Corvol P; Milliez P
    Eur J Clin Invest; 1981 Dec; 11(6):449-53. PubMed ID: 6800819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of captopril and propranolol on the responses to posture and isometric exercise in patients with essential hypertension.
    Vandenburg MJ; Holly JM; Goodwin FJ; Sharman VL; Marsh FP
    Eur J Clin Pharmacol; 1983; 25(6):721-8. PubMed ID: 6319152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Captopril: contrasting effects of adding hydrochlorothiazide, propranolol, or nifedipine.
    MacGregor GA; Markandu ND; Smith SJ; Sagnella GA
    J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S82-7. PubMed ID: 2580182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.